Menu

Verona Pharma plc VRNA

Full chart Compare
Set alert

Price alert · VRNA

All alert types
106.91 0.00 (+0.00%)

At closeOct 7, 2025, 4:00 PM EDT

106.91 Day range 106.91
31.60 52-week range 106.93
YTD
+130.21%
1 year
+233.99%

Revenue & Expenses

Revenue → Gross Profit: $31.71MGross Profit → Expenses: $31.71MRevenue → Cost of Revenue: $2.06MExpenses → Selling, General & Admin: $119.61MExpenses → Research & Development: $35.60MExpenses → Other Expenses: $6.79MExpenses → Income Tax: $8.22MNet Loss → Expenses: $138.52MGross Profit$31.71MNet Loss$138.52MCost of Revenue$2.06MExpenses$170.22MSelling, General & Admin$119.61MResearch & Development$35.60MOther Expenses$6.79MIncome Tax$8.22MRevenue$33.77M

Latest period ending Dec 31, 2024 · select a line to chart its full history

VRNA annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
42.28M0458.00K40.00M0
39.70M0112.00K40.00M0
-154.63M-67.57M-75.75M-73.31M-74.28M
-173.42M-54.37M-68.70M-55.57M-65.15M
-2.16-0.72-1.04-0.96-2.00
VRNA annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
399.76M271.77M227.83M148.38M187.99M
474.24M308.12M259.47M186.59M204.21M
269.68M58.84M29.00M38.58M19.35M
228.81M51.33M10.65M5.81M5.95M
204.56M249.28M230.47M148.00M184.85M
VRNA annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-122.20M-50.22M-59.86M-33.25M-45.08M
-580.00K0-29.00K-12.00K9.71M
250.78M92.87M140.82M-6.12M192.34M
-580.00K0-29.00K-12.00K-82.00K
127.98M43.95M79.45M-39.61M157.56M